The Union Health Ministry of India has approved Corbevax as a heterologous COVID-19 booster dose under emergency use authorization for individuals aged 18 years.
India's Permanent Mission to the United Nations, Geneva, revealed that the country has contributed $ 400,000 (over Rs 3 crore) to as many as four Voluntary Trust Funds.